BSE
MARKET ANALYSIS NEWS CORPORATE INFORMATION CORPORATE ACTIONS OTHER MARKETS
Your Result on : Company News
Alivus Life Sciences Ltd Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
543322
ISIN Demat
INE03Q201024
Book Value (Rs)
271.41036
NSE Symbol
ALIVUS
Divident Yield %
0.36
Market Cap
(Rs In Cr.)
16,866
P/E (TTM)
27.13
EPS (TTM)
50.64
Face Value
(Rs)
2
Date Heading
07-Aug-26 Alivus Life Sciences to conduct AGM
06-Aug-26 Alivus Life Sciences fixes record date for dividend
31-Jul-26 Alivus Life Sciences standalone net profit rises 31.71% in the June 20
24-Jul-26 Alivus Life Sciences to table results
24-Jul-26 Alivus Life Sciences to discuss results
18-May-26 Alivus Life Sciences rises after Q4 PAT climbs 15% YoY to Rs 163 cr
16-May-26 Alivus Life Sciences Q4 PAT climbs 15% YoY to Rs 163 cr
15-May-26 Alivus Life Sciences standalone net profit rises 14.65% in the March 2
15-May-26 Board of Alivus Life Sciences recommends final dividend
08-May-26 Alivus Life Sciences to declare Quarterly Results
22-Jan-26 Alivus Life Sciences allots 55,000 equity shares under ESOS
22-Jan-26 Alivus Life Sciences standalone net profit rises 9.71% in the December
Risk Factor   |   Terms & Conditions   |   Privacy Policy   |   Disclaimer   |  Sitemap 
Important Links:   SEBI   |   NSE   |   BSE   |   MCX   |   NCDEX   |   NSDL   |   CDSL  |   FMC
SMS FINANCIAL SERVICES P. LTD -NSE SEBI No. AP1413004363 | BSE SEBI No. AP01091801121968
Ganesh S Shanbhag – AMFI Registered Mutual Fund Distributor. Registration Number – ARN-0988 – Valid Till 01/JUL/ 2027, Date of initial registration: 02/DEC/2004
2017-18 © SMS Financial Services. All rights reserved. Designed, Developed and Maintained by CMOTS InfoTech (ISO 9001:2015 & ISO/IEC 27001:2022 Certified)